Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 6, 2007, Pages 1182-1188

  Kim, Dajung J ^a   Lyoo, In Kyoon ^a,e   Yoon, Sujung J ^b   Choi, Taeyoung ^c   Lee, Byungchol ^d   Kim, Jieun E ^a   Lee, Joonsun S ^a   Renshaw, Perry F ^e  

^a Seoul National University Hospital   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d Hallym University Medical Center   (South Korea)

^e MCLEAN HOSPITAL   (United States)

Author keywords

Bipolar disorder; Lactate; Magnetic resonance spectroscopy; Quetiapine

Indexed keywords

CARBAMAZEPINE; DRUG METABOLITE; LACTIC ACID; LITHIUM; MOOD STABILIZER; QUETIAPINE; VALPROIC ACID;

ADULT; AGITATION; ANXIETY; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FRONTAL CORTEX; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; MALE; PATIENT COMPLIANCE; PROTON NUCLEAR MAGNETIC RESONANCE; RAPID CYCLING BIPOLAR DISORDER; RATING SCALE; SCORING SYSTEM; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FEMALE; HUMANS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; SEVERITY OF ILLNESS INDEX;

EID: 34447520212     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.04.009     Document Type: Article

References (29)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Text revision (DSM-IV-TR). 4th edition (2000), American Psychiatric Press, Washington, DC
2. Atmaca M., Yildirim H., Ozdemir H., Ogur E., and Tezcan E. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol Med 37 (2007) 121-129
3. Bowden C.L., Calabrese J.R., McElroy S.L., Rhodes L.J., Keck Jr. P.E., Cookson J., et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry 45 (1999) 953-958
4. Calabrese J.R., Rapport D.J., Findling R.L., Shelton M.D., and Kimmel S.E. Rapid-cycling bipolar disorder. In: Marneros A., and Angst J. (Eds). Bipolar disorders. 100 years after manic-depressive insanity (2000), Kluwer, Boston 89-109
5. Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162 (2005) 1351-1360
6. Coryell W., Solomon D., Turvey C., Keller M., Leon A.C., Endicott J., et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 60 (2003) 914-920
7. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61 (2004) 450-458
8. Dunayevich E., and Strakowski S.M. Quetiapine for treatment-resistant mania. Am J Psychiatry 157 (2000) 1341
9. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I. Disorders, Patient edition (SCID-P), version 2 (1995), Biometrics Research Department, New York State Psychiatric Institute, New York
10. Friedman S.D., Dager S.R., Parow A., Hirashima F., Demopulos C., Stoll A.L., et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 56 (2004) 340-348
11. Garver D.L. Review of quetiapine side effects. J Clin Psychiatry 61 (2000) 31-33
12. Ghaemi S.N., and Katzow J.J. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 11 (1999) 137-140
13. In: Guy W. (Ed). CGI clinical global impressions (1976), US Department of Health, Education, and Welfare, Rockville, MD
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
15. Kato T., and Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2 (2000) 180-190
16. Modica-Napolitano J.S., Lagace C.J., Brennan W.A., and Aprille J.R. Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Arch Pharm Res 26 (2003) 951-959
17. Moore G.J., Bebchuk J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B., et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol Psychiatry 48 (2000) 1-8
18. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 27 (1993) 138-145
19. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
20. Sachs G., Chengappa K.N., Suppes T., Mullen J.A., Brecher M., Devine N.A., et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 6 (2004) 213-223
21. Sanger T.M., Tohen M., Vieta E., Dunner D.L., Bowden C.L., Calabrese J.R., et al. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord 73 (2003) 155-161
22. Stork C., and Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10 (2005) 900-919
23. Vieta E., Gasto C., Colom F., Martinez A., Otero A., and Vallejo J. Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol 18 (1998) 172-174
24. Vieta E., Parramon G., Padrell E., Nieto E., Martinez-Aran A., Corbella B., et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 4 (2002) 335-340
25. Vieta E., Mullen J., Brecher M., Paulsson B., and Jones M. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin 21 (2005) 923-934
26. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. NeuroReport 13 (2002) 2133-2137
27. Yatham L.N., Paulsson B., Mullen J., and Vagero A.M. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 24 (2004) 599-606
28. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
29. Zarate Jr. C.A. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry 61 (2000) 52-61